Copernicus Capital Management, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.

Quarter-by-quarter ownership
Copernicus Capital Management, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$3,323,000
+37.8%
135,946
+46.2%
8.52%
+87.6%
Q4 2018$2,412,000
+78.0%
93,000
+117.2%
4.54%
+257.0%
Q3 2018$1,355,000
-75.8%
42,822
-70.3%
1.27%
-68.8%
Q2 2018$5,609,000
+88.2%
144,382
+33.7%
4.07%
+71.4%
Q1 2018$2,981,000108,0002.38%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders